Pfizer (PFE) CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if necessary, as the Trump administration considers imposing tariffs on pharmaceuticals.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer CEO says the drugmaker is prepared to shift manufacturing to the US amid tariff threats )
Also on site :
- Nigeria: UK Court Rules Against Shell Over Nigerian Oil Spill
- How Development Banks Could Unlock Billions for Renewable Energy
- Flipster und Aptos Foundation kooperieren, um die Verbreitung von Stablecoin zu fördern und Multichain-Gelegenheiten zu erschließen